Projeto
Astrosomes: Artificial Astrocytes as a Novel Therapeutic to Amyotrophic Lateral Sclerosis ALS
| Referência: | SFRH/BD/147277/2019 |
|---|---|
| Organização financiadora: | Fundação para a Ciência e a Tecnologia |
| Instituições associadas: | Universidade de Lisboa |
Registos relacionados
Characterization of neuromodulatory dysfunction in Amyotrophic Lateral Sclerosis ALS.
Astrosomes: Artificial Astrocytes as a Novel Approach to Regulate Neuronal Communication
BRinging Artificial INTelligencE home for a better cAre of amyotrophic lateral sclerosis and multiple SclERosis
Sampling and biomarker OPtimization and Harmonization In Amyotrophic Lateral Sclerosis (ALS) and other motor neuron diseases (SOPHIA)
Respiratory Rehabilitation in Amyotrophic Lateral Sclerosis: clinical and biochemical impact
Novel therapeutic approach to ALS: targeting aberrant-like astrocytes before transplantation
DISSECTING THE MECHANISMS OF MICROGLIA RESPONSE, DETERMINANTS AND BIOMARKERS IN AMYOTROPHIC LATERAL SCLEROSIS
ONTology-based Web Database for Understanding Amyotrophic Lateral Sclerosis<br>
DISSECTING THE MECHANISMS OF MICROGLIA RESPONSE, DETERMINANTS AND BIOMARKERS IN AMYOTROPHIC LATERAL SCLEROSIS
Using AFM to study erythrocytes biophysical properties on cardiovascular diseases and amyotrophic lateral sclerosis
Using AFM to study erythrocytes biophysical properties on cardiovascular diseases and amyotrophic lateral sclerosis
Comprehensive Evaluation of Circulating MicroRNA as Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis
Development of an autologous exosome-based therapy by engineering microRNAs in microglia and motor-neurons using mice and human models of amyotrophic lateral sclerosis (ALS)
Efficacy and safety of low-dose IL-2 (ld-IL-2) as a Treg enhancer for anti-neuroinflammatory therapy in newly diagnosed Amyotrophic Lateral Sclerosis (ALS) patients
Functionalized lipid nanocarriers for enhancement of blood-brain barrier BBB permeability in the treatment of amyotrophic lateral sclerosis
Astrosomes: a novel approach for the regulation of neuronal communication
TE ROLE OF S100B IN MULTIPLE SCLEROSIS: FROM A BIOMARKER TO A THERAPEUTIC TARGET
Emerging Simplex ORigins In ALS
Neuron-astrocyte interactions in depression: disclosing more effective therapeutic targets [IF/00328/2015/CP1294/CT0002]
The impact of neuron-astrocyte networks on cognitive function in depression
Commercialization of a first in class multiple sclerosis drug [780807]
Multiple Sclerosis: Studying lipocalin 2 as a novel player in the pathophysiology of the disease [EXPL/NEU-OSD/2196/2013]
Unraveling the nutritional determinants in Multiple Sclerosis Multiple Sclerosis patient samples Alterado para: Unravelling longitudinal mitochondrial DNA mutations in Multiple Sclerosis: association with disease activity and progression
How do astrocytes control absence seizures and their comorbid cognitive deficits
Novel therapeutic approaches to target GNE Myopathy
MISTRAL – novel 4-amino- and 4,9-diamino-acridines as MultI-STage antimalaRiALs
Targeting glioblastoma: a novel therapeutic approach based on natural products
Uncoupling heart and liver laterality events during embryogenesis.
Uncoupling heart and liver laterality events during embryogenesis.
Identification of novel therapeutic targets to modulate proteostasis in humans
ROLE OF GLIAL CELLS AS CONTRIBUTORS TO THE ONSET AND PROPAGATION OF ALS DISEASE
The role of the astrocytic metabotropic glutamate receptor 5 in the pathophysiology of depression [2020.05109.BD]
European multidisciplinary ALS network identification to cure motor neuron degeneration
MODULATION OF THE BIDIRECTIONAL COMMUNICATION BETWEEN NEURONS AND ASTROCYTES AT THE SYNAPSE: INFLUENCE OF BDNF AND P2 RECEPTORS
Cerâmica do Gharb al- Ândalus: Contribuições para a memória intercultural em território português
Orphan CFTR mutations - from disease mechanisms to novel therapeutic opportunities
Publicações relacionadas
Carregando publicações...